Operator
Welcome to Medicenna Therapeutics KOL Webinar. [Operator Instructions] As a reminder, this convention name is being recorded. When you have any objections, please disconnect right now. I would now like to show the decision over to Dr. Fahar Service provider, President and CEO.
Fahar Service provider
Founder, Chairman, President & CEO
Good morning, good afternoon, everybody, and thanks for becoming a member of us at present. My identify is Dr. Fahar Service provider, President and CEO of Medicenna Therapeutics. We’re thrilled to welcome you to this unique webinar as we talk about thrilling new medical information from our ABILITY-1 research evaluating MDNA11. Earlier than we start, I would wish to remind everybody that this webinar comprises forward-looking statements throughout the which means of relevant securities legal guidelines. Ahead-looking statements could also be recognized by means of phrases equivalent to imagine, could, will, proceed, anticipate, intend, count on, ought to, would, may, plan, potential, promise and comparable expressions. These forward-looking statements are topic to dangers and uncertainties, together with, however not restricted to the dangers inherent in medical drug improvement, regulatory approval processes, aggressive elements and different dangers described in Medicenna’s filings with the Securities and Trade Fee and Relevant Canadian Securities regulators.
Precise outcomes could differ materially from these expressed or implied by forward-looking statements Medicenna disclaims any obligation to replace these forward-looking statements, besides as required by regulation. For
